Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2018-08-10
2021-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Purpose: To examine the impact of daily pecan consumption with and without dietary substitution instructions for an 8-week period on markers of health in adults at risk for cardiovascular disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Ability of Pecan Consumption to Improve Vascular Function and Reduce Chronic Disease Risk in Aging Adults
NCT04385537
Cardiometabolic Effects of Pecan Snacking in Prediabetes
NCT07235358
Pecan Consumption and Cognitive Function
NCT05230212
Cardiometabolic Effects of Pecans as a Snack
NCT05071807
Diet Quality, Pecans, and Cardiometabolic Health
NCT04487808
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There was a screening visit and 3 testing visits: Baseline (visit 1), mid-visit at week 4 (visit 2), and post-visit at week 8 (visit 3). Anthropometrics, questionnaires, and a fasting blood sample were collected at each visit. A subset of participants participated in a saturated fatty acid meal challenge in which additional blood and metabolism measurements were collected.
Hypothesis: The investigators hypothesized that daily pecan consumption would result in significantly greater improvements in blood lipids, metabolism, and appetite compared to the control group. The investigators also hypothesized that pecan ADD group will result in a larger increase in body weight compared to the pecan SUB and control groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants in this group avoid all nuts for 8 weeks.
No interventions assigned to this group
Pecan ADD
Participants in this group consume 68 g of pecans/d with no additional dietary instructions and avoid all other nuts.
Pecan ADD
Raw pecan halves without dietary substitution instructions
Pecan SUB
Participants in this group consume 68 g of pecans/d with instructions to substitute pecans with isocaloric foods in the habitual diet. They are also instructed to avoid all other nuts.
Pecan SUB
Raw pecan halves with instructions to substitute pecans with isocaloric foods in the habitual diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pecan ADD
Raw pecan halves without dietary substitution instructions
Pecan SUB
Raw pecan halves with instructions to substitute pecans with isocaloric foods in the habitual diet
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Nut consumption \>2 servings/week or tree nut butter consumption \>3 servings/week
* Hormone replacement therapy \<5 years
* Women who are pregnant or planning to become pregnant
* Regular exercise of \>3 hours/week
* Weight gain or loss of \>5% of body weight during last 3 months
* Plans to begin a weight loss/exercise regiment
* History of medical or surgical events that could affect digestion or swallowing
* Gastrointestinal surgeries, conditions or disorders
* Chronic or metabolic diseases
* Atherosclerosis, previous myocardial infarction, stroke, cancer
* Fasting blood glucose levels \>126 mg/dl
* Blood pressure \>180/120 mmHg
* Medication use that affects digestion, absorption, metabolism
* Lipid-lowering medications
* Medications for diabetes or attention deficit disorders (with or without hyperactivity)
* Steroid/hormone therapies
* Individuals on medically prescribed or special diet
* Individuals with food allergies to foods specifically in the study
* Individuals taking fish oil supplements
* Excessive alcohol consumption (greater than 3 drinks/d for men; greater than 2 drinks/d for women)
* Tobacco or nicotine use
30 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Georgia Pecan Commission
UNKNOWN
University of Georgia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie Cooper, PhD
Associate Professor, Dept. of Foods and Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Georgia- Department of Foods and Nutrition
Athens, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Guarneiri LL, Paton CM, Cooper JA. Pecan-Enriched Diets Alter Cholesterol Profiles and Triglycerides in Adults at Risk for Cardiovascular Disease in a Randomized, Controlled Trial. J Nutr. 2021 Oct 1;151(10):3091-3101. doi: 10.1093/jn/nxab248.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00005985
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.